body protection compound bpc 157 BioWell Labs - Protective - bpc-157 injection infection case report

Well now explore the documented sermorelin side effects

Janvier, S., Cheyns, K., Canfyn, M., Goscinny, S., De Spiegeleer, B., Vanhee, C., & Deconinck, E

doi:10.1177/0269881116675512 Griffiths RR, Johnson MW, Carducci MA, et al

This often smooths out side effects, though it doubles injections

Of these 50 semaglutide-treated patients that developed anti-semaglutide antibodies, 28 patients (1.6% of the overall population) developed antibodies cross-reacting with native GLP-1.The in vitro neutralizing activity of the antibodies is uncertain at this time

So it is very hard to know what youre getting in the current retail environment of research chemicals